论文信息 - Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive with - 字舞流文

Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive with

D. Slamon | Rashi Singh | R. Callahan | A. Castrellon | A. Mani | E. Hobbs | B. DiCarlo | Brad Adams | D. Martinez | J. Berkowitz | J. Taguchi | R. Dichmann | Ivana Meglar